|
|
Directeur :
EA 2690
Institut Pasteur
de Lille
Université de Lille 2
|
| Cancer |
Mutagenèse. Génotoxicité. Cancérogenèse. Evaluation du risque. |
|
Kirkland D, Pfuhler S, Tweats D, Aardema M, Corvi R, Darroudi F, Elhajoujia, Glatt H, Hastwell P, Hayashi M, Kasper P, Kirchner S, Lynch A, Marzin D, Maurici D, Meunier JR, Müller L, Nohynek G, Parry J, Parry E, Thybaud V, Tice R, Van Benthem J, Vanparys P, White P.
How to reduce false positive results when undertaking in vitro genotoxicity testing and thus avoid unnecessary follow-up animal tests: Report of an ECVAM Workshop.
Mutat Res, 2007, 628 :31-55. |
Le Hegarat L, Le Curieux F, Nesslany F, Marzin D.
In vitro genotoxicity potential of various air pollutants: volatile organic compounds and metal oxides, alone or in combination, on rat alveolar macrophages and lung cells by the comet assay.
Mutat Res, 2007, accepted. |
Nesslany F. , Zennouche N. , Simar-Meintières S. , Talahari I. , NKili-Mboui E.N., Marzin D.
In vivo Comet assay on isolated kidney cells to discriminate genotoxic carcinogens from epigenetic carcinogens or cytotoxic compounds.
Mutat Res, 2007, 630 :28-41. |
Nesslany F, Simar-Meintieres S, Watzinger M, Talahari I, Marzin D.
Nitrilotriacetic acid: an indirect in vitro and in vivo clastogen
Environm Mol Mutagen, 2007, accepted. |
Thybaud V, Aardema M, Clement J, Dearfield K, Galloway S, Hayashi M, Jacobson-Kram D, Kirkland D, Macgregor J, Marzin D, Ohyama W, Schuler M, Suzuki H, Zeiger E.
Strategy for genotoxicity testing: Hazard identification and risk assessment in relation to in vitro testing.
Mutat Res, 2007, 627 :41-58. |
| |
Aardema MJ, Snyder RdD Spicer C, Divi K, Morita T, Mauthe RJ, Gibson DP, Soelter S, Curry PT, Thybaud V, Lorenzon G, Marzin D, Lorge E.
SFTG international collaborative study on in vitro micronucleus test III. Using CHO cells.
Mutat Res, 2006, 607:61-87. |
Clare Mg, Lorenzon G, Akhurst Lc, Marzin D, Van Delft J, Montero R, Botta A, Bertens A, Cinelli S, Thybaud V, Lorge E.
SFTG international collaborative study on in vitro micronucleus test II. Using human lymphocytes.
Mutat Res, 2006, 607(1):37-60. |
Lorge E, Thybaud V, Aardema Mj, Oliver J, Wakata A, Lorenzon G, Marzin D.
SFTG international collaborative study on in vitro micronucleus test I. General conditions and overall conclusions of the study.
Mutat Res, 2006, 607:13-36. |
Oliver J, Meunier JR, Awogi T, Elhajouji A, Ouldelhkim MC, Bichet N, Thybaud V, Lorenzon G, Marzin D, Lorge E.
SFTG international collaborative study on in vitro micronucleus test V. Using L5178Y cells.
Mutat Res, 2006, 607:125-152. |
Wakata A, Matsuoka A, Yamakage K, Yoshida J, Kubo K, Kobayashi K, Senjyu N, Itoh S, Miyajima H, Hamada S, Nishida S, Araki H, Yamamura E, Matsui A, Thybaud V, Lorenzon G, Marzin D, Lorge E.
SFTG international collaborative study on in vitro micronucleus test IV. Using CHL cells.
Mutat Res, 2006, 607:88-124. |
|
|
